Supplementary Figure S1. from Decreased Serum Thrombospondin-1 Levels in Pancreatic Cancer Patients Up to 24 Months Prior to Clinical Diagnosis: Association with Diabetes Mellitus
Year: 2023
Type: supplementary-materials
Abstract: (A) Peptides unique to TSP-1 (in red) were used to quantify the protein using multiple reaction monitoring (MRM). (B) Detection of TSP-1 by western analysis in UKCTOCS and PBRU samples. Human Foreskin Fibroblast (HFF) cells treated with TSP-1-targeting and control siRNAs were used to validate the antibody.
Authors: Claire Jenkinson, Victoria L. Elliott, Anthony Evans, Lucy Oldfield, Rosalind E. Jenkins, Darragh P. O'Brien, Sophia Apostolidou, Aleksandra Gentry-Maharaj, Evangelia-O Fourkala, Ian J. Jacobs, Usha Menon, Trevor Cox, Fiona Campbell, Stephen P. Pereira, David A. Tuveson, B. Kevin Park, William Greenhalf, Robert Sutton, John F. Timms, John P. Neoptolemos, Eithne Costello
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4362461118